American Financial Group’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,918
Closed -$774K 63
2024
Q3
$774K Hold
30,918
0.33% 45
2024
Q2
$662K Hold
30,918
0.28% 49
2024
Q1
$574K Hold
30,918
0.22% 55
2023
Q4
$502K Buy
30,918
+1,316
+4% +$16.8K 0.18% 59
2023
Q3
$409K Buy
29,602
+3,286
+12% +$51.8K 0.14% 69
2023
Q2
$582K Hold
26,316
0.18% 65
2023
Q1
$572K Hold
26,316
0.18% 67
2022
Q4
$479K Hold
26,316
0.16% 73
2022
Q3
$599K Hold
26,316
0.21% 65
2022
Q2
$363K Hold
26,316
0.12% 75
2022
Q1
$598K Hold
26,316
0.18% 66
2021
Q4
$981K Sell
26,316
-15,000
-36% -$644K 0.27% 56
2021
Q3
$1.75M Sell
41,316
-50,000
-55% -$2.41M 0.46% 46
2021
Q2
$4.06M Buy
+91,316
New +$3.22M 1.04% 33

Other funds holding BLFS

American Financial Group's BLFS Position: Q4 2024 in Review

American Financial Group sold out of BioLife Solutions (BLFS) in Q4 2024, closing a stake of 30,918 shares — an estimated $774K sold.

American Financial Group first reported a position in BLFS in Q2 2021 and held it in 14 quarters. The position peaked at $4.06M in Q2 2021. 180 funds tracked by Wall St. Rank hold BLFS as of Q4 2024.

  • American Financial Group reported no remaining BioLife Solutions position as of Q4 2024 after selling out during the quarter.
  • American Financial Group sold 30,918 BioLife Solutions shares in Q4 2024, an estimated $774K.
  • American Financial Group first reported a position in BioLife Solutions in Q2 2021 and held it in 14 quarters.
  • American Financial Group's BioLife Solutions position peaked at $4.06M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2024.

Based on American Financial Group's 13F filing for Q4 2024, filed 11 Feb 2025.